efficacy of oral semaglutide and safety once-daily 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial Efficacy and safety of oral

The evidence presented here is meant to inform that decision, not make it for you

Acknowledgments Technical assistance was provided by Annette F Bjerre, Marianne B Jensen, Pia Jensen, Lenette S Jrgensen, Anette Kirstine Lauridsen, Gitte Norup, Jette E Svendsen and Lene Walander

It can be enough for some people

Gauge (G) needle thickness Gauge measures how thin the needle is

Denifanstat-treated patients also showed statistically significant fibrosis improvement by 1 stage with no worsening of NASH, and a greater proportion of MRI-derived proton density fat fraction (MRI-PDFF) 30% responders relative to placebo

18 In these patients, pre-existing risk factors for biliary disease, such as insulin resistance (IR), dyslipidemia, and metabolic alterations, predispose them to abnormal bile composition and an increased risk of gallstone formation